CD8A and neoplasm: Additionally, it has been shown that IL-1 receptor signaling by its extracellular ligands can also boost anti-tumor immunity, via recruitment and activation of antigen presenting cells to lymph nodes, where they can induce the activation, expansion and development of immunological memory in CD4+ and CD8+ T cells specific to tumor-associated antigens [25].